Target: the FOXO4-p53 protein interaction in senescent cells
The choice between US and Mexican peptide therapy depends on your priorities regarding cost, safety, and medical oversight
These companies are well positioned because they can combine medical oversight, convenient access, regulated production partners, and credible consumer brands
Gradual dose titration, dietary modifications, and adequate hydration help minimise gastrointestinal adverse effects and improve treatment tolerance
Both these peptide species are trimmed at their N-term, and inactivated by the ubiquitous protease dipeptidyl-peptidase-IV (DPP-IV), found in the intestinal capillaries, vena porta and liver
modern screening allows refrigerated biologics through security when properly documented